Lorlatinib in ALK- or ROS1-Positive Non-Small Cell Lung Cancer Patients: Experience from an Early Access Program in Turkey

KILIÇKAP S., Demirci U., Bugdayci F., Tural D., Korkmaz T., PAYDAŞ S., ...More

JOURNAL OF THORACIC ONCOLOGY, vol.14, no.10, 2019 (SCI-Expanded) identifier

  • Publication Type: Article / Abstract
  • Volume: 14 Issue: 10
  • Publication Date: 2019
  • Doi Number: 10.1016/j.jtho.2019.08.1166
  • Journal Name: JOURNAL OF THORACIC ONCOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Keywords: ALK positive, ROS1 positive, Lorlatinib, Advanced stage lung cancer
  • Kocaeli University Affiliated: Yes